Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17327409 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT
Condition: Immune Thrombocytopenic Purpura
Intervention: Drug: Eltrombopag and dexamethasone

Study has passed its completion date and status has not been verified in more than two years.